|Some Angiotensin Receptor Blockers More Potent Than Others|
Different angiotensin receptor blockers have distinct potencies for suppressing adrenal β-arrestin1-dependent post-myocardial infarction hyperaldosteronism, according to a letter published in the Dec. 30 issue of the Journal of the American College of ...
Doctors Lounge - Mon, 09 Feb 2015 09:37
|Electrolytes in cardiology|
Hypokalaemia can also be due to increased loss of potassium through renal excretion, which may be caused by diabetes insipidus, hypercalcaemia, hyperaldosteronism, excessive fluid replacement therapy and diarrhoea. A typical ECG for a patient with ...
The Pharmaceutical Journal - Tue, 03 Feb 2015 09:43
|Researcher Discovers Certain ARB Drugs Are More Effective Than Others at ...|
25, 2014) in an article titled “Different Potencies of Angiotensin Receptor Blockers at Suppressing Adrenal β-Arrestin1-Dependent Post-Myocardial Infarction Hyperaldosteronism.” Results of the study are also published in Scientific Reports (Vol. 5, Jan.
Newswise (press release) - Mon, 02 Feb 2015 13:11
|Expert examines contribution of aldosterone in obesity-related hypertension|
Majewski also stressed that obesity-related hyperaldosteronism is different than true primary hyperaldosteronism. Guidelines from The Endocrine Society recommend that screening for primary hyperaldosteronism occur in patients with hypertension and ...
Healio - Fri, 24 Oct 2014 13:09
|Endocrine system diseases|
Consider hyperaldosteronism Subscription. By Nadhia Bashir, Scott Akker, Hasanin Khachi. It is estimated that primary hyperaldosteronism is the cause of hypertension in as much as 5 per cent of patients. This article focuses of the two most common ...
The Pharmaceutical Journal - Mon, 01 Dec 2014 10:13
|GSK announces 14 winners of Discovery Fast Track Challenge|
Morris Brown, University of Cambridge (UK): Primary hyperaldosteronism; Dr. Federica Briani, Università degli Studi di Milano (Italy): Targeting bacterial infections; Dr. Christos Chatziantoniou, National Institute of Health and Medical Research ...
MedCity News - Mon, 01 Dec 2014 03:48
|GSK names drug hunter challenge winners|
PMLiVE - Tue, 02 Dec 2014 02:41
|Winners of GSK Discovery Fast Track Challenge Announced|
Genetic Engineering & Biotechnology News - Mon, 01 Dec 2014 11:07
|Cambridge dominates GSK medical discovery challenge|
Business Weekly - Wed, 03 Dec 2014 01:45
|Estrogen May Protect Heart by Inhibiting Mineralocorticoid|
Several anti-mineralocorticoid diuretics have been approved and are used to treat chronic heart failure, hypertension and a condition known as hyperaldosteronism. "These drugs act on the mineralocorticoid receptor in the kidneys to lower blood pressure ...
MedPage Today - Sun, 09 Nov 2014 12:05
|Severe Sleep Apnea Linked to Resistant Hypertension|
Severe obstructive sleep apnea may interfere with blood pressure (BP)–lowering treatment in patients at high cardiovascular disease risk or with established cardiovascular disease, results of a multicenter clinical trial suggest. Doctors should ...
Medscape - Thu, 02 Oct 2014 13:48